Cryoport [CYRX] vs Pitney Bowes [PBI] Detailed Stock Comparison

Cryoport

Pitney Bowes
TLDR: Quick Comparison Summary
Based on 20 vital metrics comparison: Cryoport wins in 4 metrics, Pitney Bowes wins in 14 metrics, with 0 ties. Pitney Bowes appears stronger overall.
View Metrics Details
Vital Metrics Comparison
Metric | Cryoport | Pitney Bowes | Better |
---|---|---|---|
P/E Ratio (TTM) | -4.02 | 13.76 | Cryoport |
Price-to-Book Ratio | 1.03 | -3.73 | Pitney Bowes |
Debt-to-Equity Ratio | 44.34 | -3.77 | Pitney Bowes |
PEG Ratio | 0.02 | -0.06 | Pitney Bowes |
EV/EBITDA | -13.76 | 9.62 | Cryoport |
Profit Margin (TTM) | 31.67% | -5.60% | Cryoport |
Operating Margin (TTM) | -21.23% | 15.47% | Pitney Bowes |
EBITDA Margin (TTM) | N/A | 15.47% | N/A |
Return on Equity | -9.19% | 35.20% | Pitney Bowes |
Return on Assets (TTM) | -4.21% | 4.47% | Pitney Bowes |
Free Cash Flow (TTM) | $-37.59M | $156.77M | Pitney Bowes |
Dividend Yield | N/A | 1.54% | N/A |
1-Year Return | 42.41% | 61.71% | Pitney Bowes |
Price-to-Sales Ratio (TTM) | 2.10 | 0.96 | Pitney Bowes |
Enterprise Value | $331.48M | $3.62B | Pitney Bowes |
EV/Revenue Ratio | 1.39 | 1.84 | Cryoport |
Gross Profit Margin (TTM) | 47.03% | 53.59% | Pitney Bowes |
Revenue per Share (TTM) | $5 | $11 | Pitney Bowes |
Earnings per Share (Diluted) | $-1.00 | $0.80 | Pitney Bowes |
Beta (Stock Volatility) | 1.61 | 1.26 | Pitney Bowes |
Cryoport vs Pitney Bowes Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
Stock | 1D | 1W | 1M | 3M | 6M | YTD |
---|---|---|---|---|---|---|
Cryoport | -6.44% | 6.20% | 0.91% | 32.71% | 85.45% | 24.56% |
Pitney Bowes | -5.12% | 2.31% | -1.79% | 5.59% | 35.81% | 59.70% |
Long-term Returns
Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
---|---|---|---|---|---|---|
Cryoport | 42.41% | -58.84% | -78.67% | 279.39% | 4.85% | -98.67% |
Pitney Bowes | 61.71% | 310.32% | 89.02% | -44.57% | -47.26% | -72.29% |
News Based Sentiment: Cryoport vs Pitney Bowes
Cryoport
News based Sentiment: MIXED
Cryoport is making strategic moves to expand its global footprint, but its recent financial performance is mixed, with negative revenue growth and profitability concerns. Insider selling adds another layer of complexity, creating a balanced investment narrative.
Pitney Bowes
News based Sentiment: MIXED
The month featured a significant leadership change with the election of a new Board Chair, but this was coupled with a downward revision of revenue guidance. While the leadership change is positive, the reduced outlook creates uncertainty, resulting in a mixed overall investment story.
Performance & Financial Health Analysis: Cryoport vs Pitney Bowes
Metric | CYRX | PBI |
---|---|---|
Market Information | ||
Market Cap | $490.66M | $1.94B |
Market Cap Category | Small cap | Small cap |
10 Day Avg. Volume | 497,290 | 2,468,800 |
90 Day Avg. Volume | 593,737 | 2,877,707 |
Last Close | $9.30 | $10.94 |
52 Week Range | $4.58 - $10.46 | $6.66 - $13.11 |
% from 52W High | -11.09% | -16.55% |
All-Time High | $768.00 (Nov 21, 2005) | $73.31 (Apr 26, 1999) |
% from All-Time High | -98.79% | -85.08% |
Growth Metrics | ||
Quarterly Revenue Growth | 0.15% | -0.06% |
Quarterly Earnings Growth | -0.21% | -0.42% |
Financial Health | ||
Profit Margin (TTM) | 0.32% | -0.06% |
Operating Margin (TTM) | -0.21% | 0.15% |
Return on Equity (TTM) | -0.09% | 0.35% |
Debt to Equity (MRQ) | 44.34 | -3.77 |
Cash & Liquidity | ||
Book Value per Share (MRQ) | $9.49 | $-3.06 |
Cash per Share (MRQ) | $8.51 | $1.75 |
Operating Cash Flow (TTM) | $-16,720,000 | $243.93M |
Levered Free Cash Flow (TTM) | $-11,699,250 | $229.59M |
Dividends | ||
Last 12-Month Dividend Yield | N/A | 1.54% |
Last 12-Month Dividend | N/A | $0.16 |
Valuation & Enterprise Metrics Analysis: Cryoport vs Pitney Bowes
Metric | CYRX | PBI |
---|---|---|
Price Ratios | ||
P/E Ratio (TTM) | -4.02 | 13.76 |
Forward P/E | -10.10 | 11.01 |
PEG Ratio | 0.02 | -0.06 |
Price to Sales (TTM) | 2.10 | 0.96 |
Price to Book (MRQ) | 1.03 | -3.73 |
Market Capitalization | ||
Market Capitalization | $490.66M | $1.94B |
Enterprise Value | $331.48M | $3.62B |
Enterprise Value Metrics | ||
Enterprise to Revenue | 1.39 | 1.84 |
Enterprise to EBITDA | -13.76 | 9.62 |
Risk & Other Metrics | ||
Beta | 1.61 | 1.26 |
Book Value per Share (MRQ) | $9.49 | $-3.06 |
Financial Statements Comparison: Cryoport vs Pitney Bowes
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
Metric (MRQ) | CYRX | PBI |
---|---|---|
Revenue/Sales | $41.04M | $493.42M |
Cost of Goods Sold | $22.40M | $224.30M |
Gross Profit | $18.64M | $269.12M |
Research & Development | $3.93M | $4.76M |
Operating Income (EBIT) | $-9.48M | $96.59M |
EBITDA | $-2.14M | $100.73M |
Pre-Tax Income | $-8.79M | $46.73M |
Income Tax | $234,000 | $11.31M |
Net Income (Profit) | $-11.98M | $35.42M |
Balance Sheet & Liquidity Metrics (MRQ)
Metric (MRQ) | CYRX | PBI |
---|---|---|
Cash & Equivalents | $36.10M | $323.79M |
Total Current Assets | $411.28M | $1.18B |
Total Current Liabilities | $74.03M | $1.49B |
Long-Term Debt | $224.19M | $2.00B |
Total Shareholders Equity | $398.81M | $-535.88M |
Retained Earnings | $-769.16M | $2.65B |
Property, Plant & Equipment | $119.58M | $342.09M |
Cash Flow Statement Comparison (MRQ)
Metric (MRQ) | CYRX | PBI |
---|---|---|
Operating Cash Flow | $-6.40M | $94.41M |
Capital Expenditures | $-3.17M | N/A |
Free Cash Flow | $-8.42M | $-33.57M |
Debt Repayment | $-192,000 | $-787.19M |
Common Stock Repurchase | N/A | $-15.00M |
Short Interest & Institutional Ownership Analysis
Metric | CYRX | PBI |
---|---|---|
Shares Short | 2.52M | 20.57M |
Short Ratio | 4.33 | 6.60 |
Short % of Float | 0.06% | 0.15% |
Average Daily Volume (10 Day) | 497,290 | 2,468,800 |
Average Daily Volume (90 Day) | 593,737 | 2,877,707 |
Shares Outstanding | 49.91M | 182.41M |
Float Shares | 40.88M | 157.71M |
% Held by Insiders | 0.04% | 0.01% |
% Held by Institutions | 1.02% | 0.76% |
Dividend Analysis & Yield Comparison: Cryoport vs Pitney Bowes
Metric | CYRX | PBI |
---|---|---|
Last 12-Month Dividend | N/A | $0.16 |
Last 12-Month Dividend Yield | N/A | 1.54% |
3-Year Avg Annual Dividend | N/A | $0.17 |
3-Year Avg Dividend Yield | N/A | 1.10% |
3-Year Total Dividends | N/A | $0.51 |
Ex-Dividend Date | N/A | Feb 21, 2025 |